| Print
Innoviva (INVA)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
Address
1350 Old Bayshore Highway
Suite 400
Burlingame
CA
USA
94010
Forecast key dates
| Name | Key Date |
|---|---|
| Innoviva Inc Third Quarter Earnings Results for 2026 | 2026-11-05T00:00:00 |
| Innoviva Inc Second Quarter Earnings Results for 2026 | 2026-08-06T00:00:00 |
| Innoviva Inc First Quarter Earnings Results for 2026 | 2026-05-07T00:00:00 |
| Innoviva Inc Annual Report for 2025 | 2026-02-26T00:00:00 |
| Innoviva Inc Fourth Quarter Earnings Results for 2025 | 2026-02-26T00:00:00 |
| 37th Annual Piper Sandler Healthcare Conference | 2025-12-02T16:30:00 |
Previous key dates
| Name | Key Date |
|---|---|
| 37th Annual Piper Sandler Healthcare Conference | 2025-12-02T16:30:00 |
| Innoviva Inc Third Quarter Earnings Results for 2025 | 2025-11-05T00:00:00 |
| H.C. Wainwright 27th Annual Global Investment Conference | 2025-09-08T13:00:00 |
| Cantor Global Healthcare Conference 2025 | 2025-09-04T13:00:00 |
| 2025 Wells Fargo Healthcare Conference | 2025-09-03T08:45:00 |
| Citi's 2025 Biopharma Back to School Conference | 2025-09-02T13:45:00 |
| Innoviva Inc Second Quarter Earnings Results for 2025 | 2025-08-06T00:00:00 |
| 46th Annual Goldman Sachs Global Healthcare Conference | 2025-06-09T13:20:00 |
| Innoviva Inc First Quarter Earnings Results for 2025 | 2025-05-07T00:00:00 |
| Barclays 27th Annual Global Healthcare Conference | 2025-03-11T08:30:00 |
| Innoviva Inc Fourth Quarter Earnings Results for 2024 | 2025-02-26T00:00:00 |
| Innoviva Inc Annual Report for 2024 | 2025-02-26T00:00:00 |
| Oppenheimer 35th Annual Healthcare Life Sciences Conference | 2025-02-11T14:00:00 |
| Innoviva to Participate in the Citi 2024 Global Healthcare Conference | 2024-12-05T08:45:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.